Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InspireMD (NSPR) FCF Margin (2016 - 2025)

Historic FCF Margin for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to 355.21%.

  • InspireMD's FCF Margin fell 170400.0% to 355.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 438.14%, marking a year-over-year decrease of 1361200.0%. This contributed to the annual value of 332.0% for FY2024, which is 619500.0% down from last year.
  • Per InspireMD's latest filing, its FCF Margin stood at 355.21% for Q3 2025, which was down 170400.0% from 501.07% recorded in Q2 2025.
  • In the past 5 years, InspireMD's FCF Margin registered a high of 204.37% during Q2 2023, and its lowest value of 598.5% during Q1 2025.
  • Moreover, its 5-year median value for FCF Margin was 348.05% (2024), whereas its average is 335.86%.
  • As far as peak fluctuations go, InspireMD's FCF Margin skyrocketed by 12136700bps in 2021, and later plummeted by -2504500bps in 2025.
  • Quarter analysis of 5 years shows InspireMD's FCF Margin stood at 217.97% in 2021, then crashed by -47bps to 320.66% in 2022, then increased by 22bps to 249.4% in 2023, then tumbled by -45bps to 362.29% in 2024, then grew by 2bps to 355.21% in 2025.
  • Its last three reported values are 355.21% in Q3 2025, 501.07% for Q2 2025, and 598.5% during Q1 2025.